GGrantIndex
Sort

82,697 grants matching vaccine development

Food & Waterborne Diseases Integrated Research Network

$1,412,070
Tom Besser · Washington State University · N01 · FY2009 · AI

Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive

$1,411,961
B. Kim Lee Sim · Protein Potential, Llc · R01 · FY2012 · AI

UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)

$1,411,801
Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2020 · CA

Optimization of HIV glycoproteins as vaccine candidates

$1,411,724
Jose A Lasalde-Dominicci · University Of Puerto Rico · R01 · FY2019 · AI

A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES

$1,411,690
Moriya Tsuji · Columbia University Health Sciences · N01 · FY2023 · AI

Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1

$1,411,211
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2021 · AI

UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)

$1,410,951
Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2019 · CA

Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)

$1,410,784
Peter D. Friedmann · Baystate Medical Center, Inc. · UH3 · FY2020 · DA

Rational design and efficacy testing of vaccines against HCV

$1,410,544
Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2022 · AI

Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1

$1,410,429
Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

United States Military HIV Research Program (MHRP) Clinical Trials Unit

$1,410,281
Nelson Lee Michael · Walter Reed Army Institute Of Research · UM1 · FY2017 · AI

Self-administered microneedle patches for influenza vaccines

$1,410,179
Richard W Compans · Emory University · U01 · FY2008 · AI

Rational design and efficacy testing of vaccines against HCV

$1,410,043
Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2024 · AI

SBIR Phase II: Innovative High Throughput Automated System for Individualized Poultry Vaccination and Recognition and Removal of Unhealthy Chicks

$1,409,999
Ramin Karimpour · Applied Lifesciences & Systems Poultry, Inc. · · FY2018 · TIP

HIVRAD: Structural approaches to vaccine development

$1,409,455
Dana-Farber Cancer Institute · P01 · FY2005 · AI

Technology Transfer

$1,408,761
Robert Angerer · National Institute Of Dental & Craniofacial Research · ZIK · FY2012 · DE

Aurum Clinical Trials Unit

$1,408,715
Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2024 · AI

COALITION FOR HIV VACCINE DEVELOPMENT

$1,408,462
University Of Maryland Baltimore · U01 · FY2003 · AI

Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission

$1,407,828
Manish Sagar · Boston Medical Center · R01 · FY2025 · AI

Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted

$1,407,793
J. Thomas Thomas August · Johns Hopkins University · U19 · FY2006 · AI

Viral and Host Determinants of Infant and Childhood Allergy and Asthma

$1,407,057
Ray Stokes Peebles · Vanderbilt University Medical Center · U19 · FY2017 · AI

New Scientific Approaches to Facilitate Development of Vaccines

$1,406,814
National Institute Of Allergy And Infectious Diseases · Y01 · FY2009 · AI

Adjuvant Comparison and Characterization of Peanut Antigen

$1,406,757
Herman Staats · Duke University · N01 · FY2024 · AI

The molecular pathogenesis of varicella zoster virus infection

$1,406,413
Donald Gilden · University Of Colorado Denver · P01 · FY2013 · AG

Pandemic Influenza Translational Research and novel universal countermeasure development

$1,406,345
Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI